Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 19;332(19):1669-1672.
doi: 10.1001/jama.2024.20951.

Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination

Ai-Ris Y Collier  1 , Katherine McMahan  1 , Catherine Jacob-Dolan  1 , Jinyan Liu  1 , Erica N Borducchi  1 , Bernard Moss  2 , Dan H Barouch  1
Affiliations

Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination

Ai-Ris Y Collier et al. JAMA. .
No abstract available

Plain language summary

This study assesses mpox-specific immune responses for 12 months after MVA-BN vaccination.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Collier reported grants from the Massachusetts Consortium on Pathogen Readiness (MassCPR) during the conduct of the study. Dr Barouch reported grants from the Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, Bill & Melinda Gates Foundation, Henry M. Jackson Foundation, MassCPR, National Cancer Institute, National Institute of Allergy and Infectious Diseases (NIAID), Ragon Institute, South African Medical Research Council, Walter Reed Army Institute of Research, Alkermes, CureVac, Gilead, Gritstone, GSK, Hookipa, Intima, Janssen, Legend, Leyden Labs, Musk Foundation, Novavax, Pfizer, Pharm-Olam, Sanofi, and Zentalis; equity in Celsion/Imunon; and consulting fees from Avidea, Celsion/Imunon, Laronde, Meissa, SQZ, and Sterne Kessler; and is the founder of and has equity in Vector Sciences outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Serum Mpox Antibody Responses After 2-Dose and 1-Dose Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN) Vaccination Over Time
Mpox-specific enzyme-linked immunosorbent assay (ELISA) (A and B) and 50% neutralizing antibody (NAb) titers (NT50) (C). Peak immunity was defined as 3 weeks after final vaccination. Titers less than 30 are considered negative. Horizontal red bars reflect median values. Numbers above the antigen data points reflect median titers.
See this image and copyright information in PMC

Update of

References

    1. Del Rio C, Malani PN. Update on the monkeypox outbreak. JAMA. 2022;328(10):921-922. doi: 10.1001/jama.2022.14857 - DOI - PubMed
    1. Deputy NP, Deckert J, Chard AN, et al. Vaccine effectiveness of JYNNEOS against mpox disease in the United States. N Engl J Med. 2023;388(26):2434-2443. doi: 10.1056/NEJMoa2215201 - DOI - PMC - PubMed
    1. Jacob-Dolan C, Ty D, Hope D, et al. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for mpox in rhesus macaques. Sci Transl Med. 2024;16(740):eadl4317. doi: 10.1126/scitranslmed.adl4317 - DOI - PubMed
    1. WHO director-general declares mpox outbreak a public health emergency of international concern. World Health Organization. Accessed August 21, 2024. https://www.who.int/news/item/14-08-2024-who-director-general-declares-m... - PMC - PubMed
    1. Faherty EAG, Holly T, Ogale YP, et al. Notes from the field: emergence of an mpox cluster primarily affecting persons previously vaccinated against mpox—Chicago, Illinois, March 18–June 12, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(25):696-698. doi: 10.15585/mmwr.mm7225a6 - DOI - PMC - PubMed